<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Ninety-six untreated patients with malignant <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (ML), 81 Hodgkin's disease, and 15 Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> were studied for zinc (Zn) status, and 21 patients also had <z:chebi fb="19" ids="27568">selenium</z:chebi> (Se) status analysis </plain></SENT>
<SENT sid="1" pm="."><plain>Plasma and hair Zn and Se levels were measured by atomic absorption spectrophotometry </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0011010'>Chronic</z:hpo> Zn and Se deficiencies (low plasma and low hair Zn and Se levels together) were found to be associated with ML in Turkish children </plain></SENT>
<SENT sid="3" pm="."><plain>This was most likely due to the poor "nutritional environment" of the patients because majority of the ML patients were from families of low socioeconomic status </plain></SENT>
<SENT sid="4" pm="."><plain>Supplementation of pediatric ML patients with Zn and Se, in addition to standard chemotherapy and radiotherapy regimen, is recommended </plain></SENT>
</text></document>